Clinical Trials · NCT03480022
Liraglutide 3mg (Saxenda) on Weight, Body Composition, Hormonal and Metabolic Parameters in Obese Women With PCOS
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Woman's
- Enrollment
- 88
- Start date
- Sep 2018
- Locations
- 1 site, United States
- Primary endpoint
- Absolute Body Weight (BW)